Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cancer Biother Radiopharm ; 28(7): 530-3, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23659461

RESUMEN

In this study, a microemulsion system was evaluated for delivery of mitomycin C (MMC). To track the distribution of the formulated drug after intravenous administration, radiochemical labeling and gamma scintigraphy imaging were used. The aim was to evaluate a microemulsion system for intravenous delivery of MMC and to compare its in vivo behavior with that of the MMC solution. For microemulsion formulation, soybean oil was used as the oil phase. Lecithin and Tween 80 were surfactants and ethanol was the cosurfactant. To understand the whole body localization of MMC-loaded microemulsion, MMC was labeled with radioactive technetium and gamma scintigraphy was applied for visualization of drug distribution. Radioactivity in the bladder 30 minutes after injection of the MMC solution was observed, according to static gamma camera images. This shows that urinary excretion of the latter starts very soon. On the other hand, no radioactivity appeared in the urinary bladder during the 90 minutes following the administration of MMC-loaded microemulsion. The unabated radioactivity in the liver during the experiment shows that the localization of microemulsion formulation in the liver is stable. In the light of the foregoing, it is suggested that this microemulsion formulation may be an appropriate carrier system for anticancer agents by intravenous delivery in hepatic cancer chemotherapy.


Asunto(s)
Mitomicina/administración & dosificación , Mitomicina/química , Cintigrafía/métodos , Aceite de Soja/administración & dosificación , Aceite de Soja/química , Administración Intravenosa , Animales , Emulsiones/administración & dosificación , Emulsiones/química , Cámaras gamma , Humanos , Masculino , Mitomicina/farmacocinética , Conejos , Pertecnetato de Sodio Tc 99m/administración & dosificación , Pertecnetato de Sodio Tc 99m/química , Aceite de Soja/farmacocinética , Tensoactivos/administración & dosificación , Tensoactivos/química , Tensoactivos/farmacocinética
2.
AAPS PharmSciTech ; 8(4): E91, 2007 Nov 02.
Artículo en Inglés | MEDLINE | ID: mdl-18181551

RESUMEN

The aim of the present study was to make a comparison of the in vitro release rate of diclofenac sodium (DS) from microemulsion (M) vehicles containing soybean oil, nonionic surfactants (Brij 58 and Span 80), and different alcohols (ethanol [E], isopropyl alcohol [I], and propanol [P]) as cosurfactant. The optimum surfactant:cosurfactant (S:CoS) weight ratios and microemulsion areas were detected by the aid of phase diagrams. Three microemulsion formulations were selected, and their physicochemical properties were examined for the pH, viscosity, and conductivity. According to the release rate of DS, M prepared with P showed the significantly highest flux value (0.059 +/- 0.018 mg/cm(2)/h) among all formulations (P < .05). The conductivity results showed that DS-loaded microemulsions have higher conductivity values (18.8-20.2 microsiemens/cm) than unloaded formulations (16.9-17.9 microsiemens/cm), and loading DS into the formulation had no negative effect on system stability. Moreover, viscosity measurements were examined as a function of shear rate, and Newtonian fluid characterization was observed for each microemulsion system. All formulations had appropriate observed pH values varying from 6.70 to 6.85 for topical application. A skin irritation study was performed with microemulsions on human volunteers, and no visible reaction was observed with any of the formulations. In conclusion, M prepared with P may be a more appropriate formulation than the other 2 formulations studied as drug carrier for topical application.


Asunto(s)
Antiinflamatorios no Esteroideos/química , Diclofenaco/química , Portadores de Fármacos , Emulsiones , Aceite de Soja/química , Tensoactivos/química , Agua/química , 1-Propanol/química , 2-Propanol/química , Administración Cutánea , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/efectos adversos , Cetomacrogol/química , Química Farmacéutica , Diclofenaco/administración & dosificación , Diclofenaco/efectos adversos , Composición de Medicamentos , Conductividad Eléctrica , Eritema/inducido químicamente , Etanol/química , Femenino , Hexosas , Humanos , Concentración de Iones de Hidrógeno , Cinética , Masculino , Modelos Químicos , Tamaño de la Partícula , Piel/efectos de los fármacos , Pruebas de Irritación de la Piel , Solubilidad , Aceite de Soja/administración & dosificación , Aceite de Soja/efectos adversos , Tensoactivos/administración & dosificación , Tensoactivos/efectos adversos , Tecnología Farmacéutica/métodos , Viscosidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA